BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer.

Rose, Madison M; Espinoza, Veronica L; Hoff, Katelyn J; Pike, Laura A; Sharma, Vibha; Hofmann, Marie-Claude; Tan, Aik Choon; Pozdeyev, Nikita; Schweppe, Rebecca E

Rose, Madison M; Espinoza, Veronica L; Hoff, Katelyn J; Pike, Laura A; Sharma, Vibha; Hofmann, Marie-Claude; Tan, Aik Choon; Pozdeyev, Nikita; Schweppe, Rebecca E.

Afiliação

Rose MM; Division of Endocrinology, Metabolism, and Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 7103, Aurora, CO 80045, USA.
Espinoza VL; Division of Endocrinology, Metabolism, and Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 7103, Aurora, CO 80045, USA.
Hoff KJ; Department of Cell and Developmental Biology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Pike LA; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Sharma V; Division of Endocrinology, Metabolism, and Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 7103, Aurora, CO 80045, USA.
Hofmann MC; Department of Endocrine Neoplasia & Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Tan AC; Department of Oncological Sciences, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT 84112, USA.
Pozdeyev N; Division of Endocrinology, Metabolism, and Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 7103, Aurora, CO 80045, USA.
Schweppe RE; Division of Bioinformatics and Personalized Medicine, Department Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Cancers (Basel) ; 15(2)2023 Jan 06.

Article em En | MEDLINE | ID: mdl-36672327

Palavras-chave

BIM; MAPK; Src; combination; dasatinib; targeted therapy; thyroid cancer; trametinib

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google